[1] 金银鹏,傅青春.肝硬化腹水诊治进展AASLD 2012版肝硬化腹水诊疗指南介绍. 肝脏,2013,18:638-640.
[2] 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南. 实用肝脏病杂志,2018,21:21-31.
[3] 黄强. 拉米夫定联合阿德福韦酯与恩替卡韦治疗乙肝肝硬化的疗效对比分析. 广西医学,2014,36:980-982.
[4] 王家马龙,李绍白.肝脏病学.第3版.北京:人民卫生出版社,2013:630-645.
[5] Moreau R, Jalan R, Gines P,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology, 2013,144: 1426-1437.
[6] Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology, 2015,148: 30-36.
[7] 王晓春,冯明丽,杨长青.肝硬化腹水患者的临床危险因素分析. 肝脏,2017,22:224-226.
[8] 任丽楠,祁兴顺,陈江,等.不同病因肝硬化患者血清肝纤维化指标结果分析. 胃肠病学和肝病学杂志,2017,26:23-24.
[9] 董培玲,丁惠国.肝硬化继发感染:挑战与对策.北京医学, 2011,33: 763-766. |
